← All drugs Report issue

MDX-214

mAbexperimentalBi-specific

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Immunoglobulin alpha Fc receptorAGONIST
CD89
- Immunoglobulin alpha Fc receptor (FCAR) ↗
Epidermal growth factor receptor erbB1BINDING AGENT
EGFR
- Epidermal growth factor receptor (EGFR) ↗

Chemistry & pharmacology

Multi-specific: Yes (Bi-specific)

Oral

No

Parenteral

No

Topical

No